Phosphoserine aminotransferase 1 (PSAT1) catalyzes the second step of the serine-glycine biosynthesis pathway, and its overexpression was reported in ovarian cancer [48], lung adenocarcinoma [49], and breast cancer [50]. Here, PSAT1 is linked to breast carcinoma.